Hoya appoints new executive officer
Japan | News | By BioSpectrum Bureau | 0 Comment | 26 May, 2014
Singapore: Japan based Hoya Corporation has appointed Mr Augustine Yee as its executive officer, chief legal officer and...Read more
Takeda's center among Chicago's top 100 workplaces
Japan | News | By BioSpectrum Bureau | 0 Comment | 14 Nov, 2012
Singapore: Takeda Pharmaceuticals' Deerfield campus has been listed among Chicago's top 100 workplaces by the Chicago T...Read more
Eisai launches beauty drink in Japan
Japan | News | By BioSpectrum Bureau | 0 Comment | 26 Feb, 2013
Singapore: Japan-based Eisai is going to launch its new carbonated supplement drink named 'Chocola BB Sparkling + Fiber'...Read more
Eisai seeks nod for Helicobacter Pylori treatment
Japan | News | By BioSpectrum Bureau | 0 Comment | 01 Jun, 2012
Singapore: Eisai, which has its headquarters in Tokyo, has submitted a marketing authorization application to Japan's Mi...Read more
Will Keryx's ferric citrate NDA get nod in Japan?
Japan | News | By BioSpectrum Bureau | 0 Comment | 08 Jan, 2013
Singapore: Keryx Biopharmaceuticals announced that its Japanese partner, Japan Tobacco (JT), has filed a New Drug Appli...Read more
FDA accepts sNDA for Astellas cancer drug
Japan | Regulatory | By BioSpectrum Bureau | 0 Comment | 17 Jan, 2013
Singapore: The US FDA has accepted Astellas Pharma's US subsidiary filing of a supplemental New Drug Application (sNDA) ...Read more
EMA to review marketing plea for antipsychotic medication
Japan | News | By BioSpectrum Bureau | 0 Comment | 29 Oct, 2012
Singapore: The European Medicines Agency (EMA) has accepted the marketing authorization application for review of an aty...Read more
Ranbaxy advisory: All our products are safe and efficacious
Japan | News | By BioSpectrum Bureau | 0 Comment | 03 Jun, 2013
New Delhi: Ranbaxy issued an advisory claiming that all their products in the Indian and global markets are safe and eff...Read more
Amgen to acquire Onyx for $10 bn cash
Japan | News | By BioSpectrum Bureau | 0 Comment | 26 Aug, 2013
Singapore: Global biopharmaceutical company Amgen plans to acquire all the outstanding shares of Onyx Pharmaceuticals fo...Read more
Effient trial by Daiichi, Lilly fails to meet primary endpoint
Japan | News | By BioSpectrum Bureau | 0 Comment | 27 Aug, 2012
Singapore: The TRILOGY ACS study, a phase III trial comparing prasugrel plus aspirin to clopidogrel plus aspirin in pati...Read more
Takeda ends 3-year-old-deal with Amylin
Japan | News | By BioSpectrum Bureau | 0 Comment | 26 Dec, 2012
Singapore: Takeda Pharmaceutical mutually terminated its worldwide agreement with Amylin Pharmaceuticals, which was ori...Read more
EMA committee positive on Teduglutide
Japan | Regulatory | By BioSpectrum Bureau | 0 Comment | 25 Jun, 2012
Singapore: The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a posi...Read more
Astellas Pharma opens office in Singapore
Japan | News | By BioSpectrum Bureau | 0 Comment | 12 Dec, 2013
Singapore: Astellas Pharma, Japan's pharmaceutical giant with net sales of $10.7 billion and net income of $881 million ...Read more
Sucampo gets $15 mn payment from Abbott
Japan | News | By BioSpectrum Bureau | 0 Comment | 12 Dec, 2012
Singapore: Sucampo Pharmaceuticals' subsidiary SPL has received a $15 million milestone payment from Abbott's subsidiar...Read more
Scotland approves Eisai's Fycompa
Japan | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: Eisai announched that Scotland's health technology assessment (HTA) body, the Scottish Medicines Consortium ...Read more
Zoll establishes Japanese subsidiary
Japan | News | By BioSpectrum Bureau | 0 Comment | 29 Oct, 2012
Singapore: ZOLL Medical, a manufacturer of medical devices and related software solutions and a wholly owned US subsidi...Read more
RLS, Parkinson's drug Neupro gets Japanese nod
Japan | News | By BioSpectrum Bureau | 0 Comment | 28 Dec, 2012
Singapore: The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Neupro (rotigotine transdermal patch...Read more
AVEO, Astellas cancer drug gets FDA nod
Japan | Regulatory | By BioSpectrum Bureau | 0 Comment | 29 Nov, 2012
Singapore: AVEO Oncology and Astellas Pharma announced that the US Food and Drug Administration (FDA) has accepted fo...Read more